Occult Breast Cancer: Scintimammography with High-Resolution Breast-specific Gamma Camera in Women at High Risk for Breast Cancer

References

• 1 Sickles EA. Mammographic features of early breast cancer. AJR Am J Roentgenol 1984;143:461–464.
  MedlineGoogle Scholar
• 2 Niloff PH, Sheiner NM. False-negative mammograms in patients with breast cancer. Can J Surg 1981;24:50–52.
  MedlineGoogle Scholar
• 3 Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225(1):165–175.
  Google Scholar
• 4 Khalkhali I, Mena I, Jouanne E. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491–497.
  MedlineGoogle Scholar
• 5 Khalkhali I, Cutrone JA, Mena I. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421–426.
  Google Scholar
• 6 Brem RF, Schoonjans JM, Kieper DA, Majewski S. High-resolution scintimammography: a pilot study. J Nucl Med 2002;43:909–915.
  MedlineGoogle Scholar
• 7 Khalkhali I, Villanueva-Meyer J, Edell S. Diagnostic accuracy of Tc-99m sestamibi breast imaging: multi-center trial results. J Nucl Med 2000;41(12):1973–1979.
  MedlineGoogle Scholar
• 8 Burak Z, Argon M, Memis A. Evaluation of palpable breast masses with Tc-99m-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604–612.
  MedlineGoogle Scholar
• 9 Helbich TH, Becherer A, Trattnig S. Differentiation of benign and malignant breast lesions: MR Imaging versus Tc-99m sestamibi scintimammography. Radiology 1997;202:421–429.
  Google Scholar
• 10 Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium 99-m MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med 1998;39:86–91.
  MedlineGoogle Scholar
• 11 Taillefer R, Robidoux A, Lambert R. Technetium 99-m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758–1765.
  MedlineGoogle Scholar
• 12 Clifford EJ, Lugo-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996;172:483–486.
  MedlineGoogle Scholar
• 13 Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432–436.
  MedlineGoogle Scholar
• 14 Palmedo H, Biersak HJ, Lastoria S. Scintimammography with technitium-99m methoxyisobutylisonitrile: results of a prospective European multi-center trial. Eur J Nucl Med 1998;25:375–385.
  MedlineGoogle Scholar
• 15 Tiling R, Khalkhali I, Sommer H. The role of Tc-99m sestamibi scintimammography and contrast enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Eur J Nucl Med 1997;24:1221–1229.
  MedlineGoogle Scholar
• 16 Horne T, Pappo I, Cohenpour M. Tc-99m MIBI scintimammography for the detection of breast malignancies: the contribution of the count ratio to specificity. Nucl Med Commun 1999;20:511–516.
  MedlineGoogle Scholar
• 17 Arslan N, Ozturk E, Ilgan S. Tc-99m MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Nucl Med Commun 1999;20:317–325.
  MedlineGoogle Scholar
• 18 Maffioli L, Agresti R, Chiti A, Crippa F. Prone scintimammography in patients with nonpalpable breast lesions. Anticancer Res 1996;16:1269–1274.
  MedlineGoogle Scholar
• 19 Scopinaro F, Ierardi M, Porfiri LM, et al. Tc-99m MIBI prone scintimammography in patients with high and intermediate risk mammography. Anticancer Res 1997;17:1635–1638.
  MedlineGoogle Scholar
• 20 Scopinaro F, Schillaci O, Ussof W, et al. A three center trial on the diagnostic accuracy of Tc-99m MIBI scintimammography. Anticancer Res 1997;17:1631–1634.
  MedlineGoogle Scholar
• 21 Tolmos J, Cutrone JA, Wang B. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer Inst 1998;90:846–849.
  MedlineGoogle Scholar
• 22 Palmedo H, Grunwald F, Bender H. Scintimammography with technetium-99m methoxyisobutylionitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996;23:940–946.
  MedlineGoogle Scholar
• 23 Majewski S, Kieper D, Keppel C. Optimization of dedicated scintimammography procedure using small detector prototypes and compressible breast phantoms (abstr). Presented at the IEEE Medical Imaging Conference, Lyon, France, October 2000.
  Google Scholar
• 24 Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353(9169):1993–2000.
  MedlineGoogle Scholar
• 25 Schoonjans JM, Brem RF. Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses. J Ultrasound Med 2001;20(9):967–972.
  MedlineGoogle Scholar
• 26 Waxman AD. The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 1997;27:40–54.
  MedlineGoogle Scholar
• 27 Cutrone JA, Khalkhali I, Yosper LS. Tc-99m sestamibi scintimammography for the evaluation of breast masses in patients with radiographically dense breasts. Breast J 1999;5:383–388.
  MedlineGoogle Scholar
• 28 Gupta P, Waxman A, Nguyen K. Correlation of Tc-99m sestamibi uptake with histopathologic characteristics in patients with benign breast disease (abstr). J Nucl Med 1996;37:250.
  Google Scholar
• 29 Cotran S, Lester S. The female breast. Pathologic basis of disease. 6th ed. Philadelphia, Pa: Saunders, 1999; 1100–1102.
  Google Scholar
• 30 Rice SJ, Khalkhali I, Diggles L. The role of radionuclide imaging in the evaluation of suspected breast abnormalities. Breast Dis 1998;10:177–187.
  MedlineGoogle Scholar
• 31 Taillefer R. Clinical applications of 99mTc-sestamibi scintimammography. Semin Nucl Med 2005;35:100–115.
  MedlineGoogle Scholar
• 32 Klaus AJ, Klingensmith WC 3rd, Parker SH, Stavros AT, Sutherland JD, Aldrete KD. Comparative value of Tc-99m sestamibi scintimammography and sonography in the diagnostic workup of breast masses. AJR Am J Roentgenol 2000;174:1779–1783.
  MedlineGoogle Scholar
• 33 Williams MB, Pisano ED, Schnall MD, Fajardo LL. Future directions in imaging of breast disease. Radiology 1998;206:297–300.
  Google Scholar
• 34 Kuhl CK, Mielcarek P, Klaschik S. Dynamic breast MR imaging: are the signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101–110.
  Google Scholar